Get the Stockscreener App
84.67
0.79%
0.6899
Ishares U S Pharmaceuticals Etf stock is traded at $84.67, with a volume of 163.47K.
It is up +0.79% in the last 24 hours and up +1.90% over the past month.
See More
Previous Close:
$83.98
Open:
$84.03
24h Volume:
163.47K
Relative Volume:
1.71
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.09%
1M Performance:
+1.90%
6M Performance:
+27.13%
1Y Performance:
+29.51%
1-Day Range:
$84.00
$85.30
1-Week Range:
$83.03
$85.30
52-Week Range:
$58.97
$86.32
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Name
Ishares U S Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare IHE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
84.64 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
341.27 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
692.12 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
695.18 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
269.31 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
623.82 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Stock (IHE) Latest News
4 Top-Ranked ETF Areas That Beat the Market in 2025 - The Globe and Mail
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends - The Globe and Mail
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - sharewise.com
Aug Opening: Is iShares U.S. Pharmaceutical ETF stock a top pick for value investorsPortfolio Update Report & Free Growth Oriented Trading Recommendations - Улправда
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
iShares Dow Jones US Pharmaceuticals ETF (IHE) Stock News & Articles - 24/7 Wall St.
Short bets on S&P 500 healthcare sector rises to 2.12% in November; MRNA stays most shorted stock - MSN
3 dividend ETFs to buy and hold for life if the market crashes - MSN
3 Dividend ETFs to Buy and Hold for Life if the Market Crashes - AOL.com
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
iShares U.S. Pharmaceuticals ETF $IHE Shares Sold by Brown Advisory Inc. - Defense World
The pharmaceutical sector is surging. Here's 1 stock every investor should have on their radar. - MSN
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. - The Globe and Mail
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - Yahoo Finance
Pharmaceutical Sector Surges on Policy Shifts and Innovation - Ad-hoc-news.de
Pharma Stocks in the World Market for TVC:GOLD by GlobalWolfStreet - TradingView
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - sharewise.com
Most S&P 500 healthcare stocks deliver earnings beat this week - MSN
Pharma ETF (IHE) Hit a 52-Week High - sharewise.com
iShares U.S. Pharmaceutical ETF (NY: IHE - Markets Financial Content
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - NewsBreak: Local News & Alerts
Is iShares U.S. Pharmaceutical ETF stock a top dividend aristocrat candidateEarnings Risk Report & Daily Growth Stock Tips - newser.com
Is iShares U.S. Pharmaceutical ETF stock attractive post correctionJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs - TradingView
How dovish Fed policy supports iShares U.S. Pharmaceutical ETF stockQuarterly Portfolio Summary & Expert Curated Trade Setup Alerts - newser.com
Ishares U S Pharmaceuticals Etf Stock (IHE) Financials Data
There is no financial data for Ishares U S Pharmaceuticals Etf (IHE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):